Future Oncology
Volume 19, 2023 - Issue 10
Open access
788
Views
3
CrossRef citations to date
0
Altmetric
Short Communication
Costs associated with the use of multigene panel tests in three solid tumor types and the impact on insurance premiums
William Wong1 Genentech, Inc.,
South San Francisco,
CA94080,
USACorrespondence[email protected]
https://orcid.org/0000-0002-6054-278XView further author information
Danny Sheinson1 Genentech, Inc.,
South San Francisco,
CA94080,
USAView further author information
, Yutong Liu2 Genesis Research,
Hoboken,
NJ07030,
USA
https://orcid.org/0000-0003-3473-7302View further author information
Tu My To1 Genentech, Inc.,
South San Francisco,
CA94080,
USA
https://orcid.org/0000-0001-9506-7539View further author information
Pages 705-714
|
Received 03 Feb 2023, Accepted 13 Mar 2023, Published online: 18 Apr 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.